Literature DB >> 28468800

Genetic rescue models refute nonautonomous rod cell death in retinitis pigmentosa.

Susanne F Koch1,2,3, Jimmy K Duong4, Chun-Wei Hsu1,2,3, Yi-Ting Tsai1,2,3,5, Chyuan-Sheng Lin6, Christian A Wahl-Schott7, Stephen H Tsang8,2,3,4,6.   

Abstract

Retinitis pigmentosa (RP) is an inherited neurodegenerative disease, in which the death of mutant rod photoreceptors leads secondarily to the non-cell autonomous death of cone photoreceptors. Gene therapy is a promising treatment strategy. Unfortunately, current methods of gene delivery treat only a fraction of diseased cells, yielding retinas that are a mosaic of treated and untreated rods, as well as cones. In this study, we created two RP mouse models to test whether dying, untreated rods negatively impact treated, rescued rods. In one model, treated and untreated rods were segregated. In the second model, treated and untreated rods were diffusely intermixed, and their ratio was controlled to achieve low-, medium-, or high-efficiency rescue. Analysis of these mosaic retinas demonstrated that rescued rods (and cones) survive, even when they are greatly outnumbered by dying photoreceptors. On the other hand, the rescued photoreceptors did exhibit long-term defects in their outer segments (OSs), which were less severe when more photoreceptors were treated. In summary, our study suggests that even low-efficiency gene therapy may achieve stable survival of rescued photoreceptors in RP patients, albeit with OS dysgenesis.

Entities:  

Keywords:  gene therapy; neurodegeneration; non-cell autonomous degeneration; photoreceptor cell death; retinitis pigmentosa

Mesh:

Substances:

Year:  2017        PMID: 28468800      PMCID: PMC5441755          DOI: 10.1073/pnas.1615394114

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  28 in total

1.  Pax6 is required for the multipotent state of retinal progenitor cells.

Authors:  T Marquardt; R Ashery-Padan; N Andrejewski; R Scardigli; F Guillemot; P Gruss
Journal:  Cell       Date:  2001-04-06       Impact factor: 41.582

2.  Visual cells and the concept of renewal.

Authors:  R W Young
Journal:  Invest Ophthalmol Vis Sci       Date:  1976-09       Impact factor: 4.799

3.  Rom-1 is required for rod photoreceptor viability and the regulation of disk morphogenesis.

Authors:  G Clarke; A F Goldberg; D Vidgen; L Collins; L Ploder; L Schwarz; L L Molday; J Rossant; A Szél; R S Molday; D G Birch; R R McInnes
Journal:  Nat Genet       Date:  2000-05       Impact factor: 38.330

4.  Non-cell-autonomous photoreceptor degeneration in rds mutant mice mosaic for expression of a rescue transgene.

Authors:  W Kedzierski; D Bok; G H Travis
Journal:  J Neurosci       Date:  1998-06-01       Impact factor: 6.167

5.  Successful arrest of photoreceptor and vision loss expands the therapeutic window of retinal gene therapy to later stages of disease.

Authors:  William A Beltran; Artur V Cideciyan; Simone Iwabe; Malgorzata Swider; Mychajlo S Kosyk; Kendra McDaid; Inna Martynyuk; Gui-Shuang Ying; James Shaffer; Wen-Tao Deng; Sanford L Boye; Alfred S Lewin; William W Hauswirth; Samuel G Jacobson; Gustavo D Aguirre
Journal:  Proc Natl Acad Sci U S A       Date:  2015-10-12       Impact factor: 11.205

6.  Reprogramming metabolism by targeting sirtuin 6 attenuates retinal degeneration.

Authors:  Lijuan Zhang; Jianhai Du; Sally Justus; Chun-Wei Hsu; Luis Bonet-Ponce; Wen-Hsuan Wu; Yi-Ting Tsai; Wei-Pu Wu; Yading Jia; Jimmy K Duong; Vinit B Mahajan; Chyuan-Sheng Lin; Shuang Wang; James B Hurley; Stephen H Tsang
Journal:  J Clin Invest       Date:  2016-11-14       Impact factor: 14.808

7.  The murine cone photoreceptor: a single cone type expresses both S and M opsins with retinal spatial patterning.

Authors:  M L Applebury; M P Antoch; L C Baxter; L L Chun; J D Falk; F Farhangfar; K Kage; M G Krzystolik; L A Lyass; J T Robbins
Journal:  Neuron       Date:  2000-09       Impact factor: 17.173

Review 8.  Molecular genetics of human retinal disease.

Authors:  A Rattner; H Sun; J Nathans
Journal:  Annu Rev Genet       Date:  1999       Impact factor: 16.830

9.  Cellular interactions implicated in the mechanism of photoreceptor degeneration in transgenic mice expressing a mutant rhodopsin gene.

Authors:  P C Huang; A E Gaitan; Y Hao; R M Petters; F Wong
Journal:  Proc Natl Acad Sci U S A       Date:  1993-09-15       Impact factor: 11.205

Review 10.  Genes and mutations causing retinitis pigmentosa.

Authors:  S P Daiger; L S Sullivan; S J Bowne
Journal:  Clin Genet       Date:  2013-06-19       Impact factor: 4.438

View more
  13 in total

1.  CAPN5 genetic inactivation phenotype supports therapeutic inhibition trials.

Authors:  Katherine J Wert; Susanne F Koch; Gabriel Velez; Chun-Wei Hsu; MaryAnn Mahajan; Alexander G Bassuk; Stephen H Tsang; Vinit B Mahajan
Journal:  Hum Mutat       Date:  2019-08-26       Impact factor: 4.878

2.  Limited time window for retinal gene therapy in a preclinical model of ciliopathy.

Authors:  Poppy Datta; Avri Ruffcorn; Seongjin Seo
Journal:  Hum Mol Genet       Date:  2020-08-11       Impact factor: 6.150

3.  Late-stage rescue of visually guided behavior in the context of a significantly remodeled retinitis pigmentosa mouse model.

Authors:  Jacqueline Kajtna; Stephen H Tsang; Susanne F Koch
Journal:  Cell Mol Life Sci       Date:  2022-02-23       Impact factor: 9.207

4.  Long-term vitamin A supplementation in a preclinical mouse model for RhoD190N-associated retinitis pigmentosa.

Authors:  Xuan Cui; Hye Jin Kim; Chia-Hua Cheng; Laura A Jenny; Jose Ronaldo Lima de Carvalho; Ya-Ju Chang; Yang Kong; Chun-Wei Hsu; I-Wen Huang; Sara D Ragi; Chyuan-Sheng Lin; Xiaorong Li; Janet R Sparrow; Stephen H Tsang
Journal:  Hum Mol Genet       Date:  2022-07-21       Impact factor: 5.121

5.  Genetic Rescue Reverses Microglial Activation in Preclinical Models of Retinitis Pigmentosa.

Authors:  Lijuan Zhang; Xuan Cui; Ruben Jauregui; Karen Sophia Park; Sally Justus; Yi-Ting Tsai; Jimmy K Duong; Chun-Wei Hsu; Wen-Hsuan Wu; Christine L Xu; Chyuan-Sheng Lin; Stephen H Tsang
Journal:  Mol Ther       Date:  2018-06-21       Impact factor: 11.454

Review 6.  CRISPR/Cas9 genome surgery for retinal diseases.

Authors:  Christine L Xu; Karen Sophia Park; Stephen H Tsang
Journal:  Drug Discov Today Technol       Date:  2018-06-18

7.  Perspectives on Gene Therapy: Choroideremia Represents a Challenging Model for the Treatment of Other Inherited Retinal Degenerations.

Authors:  Ian M MacDonald; Christopher Moen; Jacque L Duncan; Stephen H Tsang; Jasmina Cehajic-Kapetanovic; Tomas S Aleman
Journal:  Transl Vis Sci Technol       Date:  2020-02-14       Impact factor: 3.283

8.  Rod function deficit in retained photoreceptors of patients with class B Rhodopsin mutations.

Authors:  Artur V Cideciyan; Samuel G Jacobson; Alejandro J Roman; Alexander Sumaroka; Vivian Wu; Jason Charng; Brianna Lisi; Malgorzata Swider; Gustavo D Aguirre; William A Beltran
Journal:  Sci Rep       Date:  2020-07-28       Impact factor: 4.379

Review 9.  Retina Metabolism and Metabolism in the Pigmented Epithelium: A Busy Intersection.

Authors:  James B Hurley
Journal:  Annu Rev Vis Sci       Date:  2021-06-08       Impact factor: 6.422

10.  Biochemical adaptations of the retina and retinal pigment epithelium support a metabolic ecosystem in the vertebrate eye.

Authors:  Mark A Kanow; Michelle M Giarmarco; Connor Sr Jankowski; Kristine Tsantilas; Abbi L Engel; Jianhai Du; Jonathan D Linton; Christopher C Farnsworth; Stephanie R Sloat; Austin Rountree; Ian R Sweet; Ken J Lindsay; Edward D Parker; Susan E Brockerhoff; Martin Sadilek; Jennifer R Chao; James B Hurley
Journal:  Elife       Date:  2017-09-13       Impact factor: 8.140

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.